HeartSciences Inc. (HSCS) Cash from Investing Activities (2022 - 2025)

HeartSciences (HSCS) has reported Cash from Investing Activities for 4 consecutive years, with -$15770.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities fell 169.94% year-over-year to -$15770.0; the trailing twelve-month figure through Apr 2026 stood at -$24396.0 (up 19.19% YoY), and the FY2026 full-year result was -$44452.0, down 47.25% from the prior year.
• Cash from Investing Activities slipped to -$15770.0 in Q4 2025 per HSCS's latest filing, from -$814.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$814.0 in Q3 2025 and bottomed at -$69228.0 in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$14642.4 across 4 years, with a median of -$7247.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities tumbled 1317.73% in 2024, then surged 88.72% in 2025.
• Over 4 years, Cash from Investing Activities stood at -$7247.0 in 2022, then surged by 73.06% to -$1952.0 in 2023, then sank by 199.28% to -$5842.0 in 2024, then sank by 169.94% to -$15770.0 in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$15770.0, -$814.0, and -$7812.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.